Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

Mark Krasnik



Author of

  • +

    P2.12 - Pulmonology/Endoscopy (ID 713)

    • Event: WCLC 2017
    • Type: Poster Session with Presenters Present
    • Track: Pulmonology/Endoscopy
    • Presentations: 1
    • +

      P2.12-003 - The History of EBUS TBNA (ID 8399)

      09:30 - 09:30  |  Presenting Author(s): Mark Krasnik

      • Abstract

      Background:
      Once there were mediastinoscopy and now there is EBUS TBNA. It started in 1997. the development of a real time Ultrasound guide TBNA system were proposed in 1997 and in Dec 2002 the first EBUS TBNA paper were published Then 1 in 2003, 2 in 2004 and 3 in 2005 describing the use of EBUS TBNA for staging of the mediastinum. All ready in 2006 the first paper describing the effectiveness in combining EUS FNA and EBUS TBNA using 2 different types of scopes. This combination was not widely used until Felix Herth and his group demonstrated the usefulness of the EBUS TBNA scope in the esophagus. In 2007 the first paper on the use of EBUS TBNA in sarcoidosis was published, the first review and the use of cytology and EGF. 2008 was the year when the issue of diagnosing lymphoma was raised and the diagnosing metastases in the mediastinum from other organs and mediastinal tumors was shown feasible. 2009 was the year of the first metaanalysis and the first randomized study. The first complication was mentioned. The chemosensitivity and cell receptors were discussed. In 2010 the number of papers exploded. Restaging, TB, the number of stations punctured, one scope in esophagus and trachea, cost benefit, learning curves, sedation, elastography were the main topics. Mediastinoscopy was still the golden standard 2011 another randomized study. More papers on hematological diseases and more receptors were demonstrated in cytology and a biopsy forceps were introduced and more complications were described 2012 the 19 G needle and cell block and ROSE were introduced. The first paper using the EBUS TBNA in treatment was described. And it was the year of the ASTER trial 2013 is the year of molecular biology and EBUS TBNA. The literature from this year was characterized by the establishment of EBUS TBNA’s role in the staging and diagnostic process of cancer in the lung and mediastinum 2014 is the year of the acceptance of EBUS TBNA with the new ESTS guidelines 2015-16 is characterized of different metaanalysis and many reviews on a wide spectrum of topics using the EBUS TBNA in diferent areas of pulmonology

      Method:
      A review of the literatur

      Result:
      Section not applicable

      Conclusion:
      EBUS TBNA have in a very short time revolutionized the diagnostic of chest diseases and the staging og lung cancer. There is still room for improvement of the system and the role of EBUS TBNA is stil developing

  • +

    P3.16 - Surgery (ID 732)

    • Event: WCLC 2017
    • Type: Poster Session with Presenters Present
    • Track: Surgery
    • Presentations: 1
    • +

      P3.16-017 - The Role of Skip Metastases and the Number of Metastac Lymp Nodes in the Survival of Operated Patients (ID 8374)

      09:30 - 09:30  |  Presenting Author(s): Mark Krasnik

      • Abstract

      Background:
      The IASLC staging committe hase rased the question of the role of skip metastases and single and multple metastases in a sigle station in the hillar and mediastinal regions in survival of lung cancer

      Method:
      Based on a database with 1068 operated patients we will try to establish an aswer to these questions. We have just this week received the dataset so we did not have time for making the necessary calculations before abstract deadline

      Result:
      The reults wil be added before the next deadline

      Conclusion:
      Will be added before the next deadline